TKT and cytomegalovirus infection: However, there are some disadvantages related to the use of HSV-Tk genes, such as the immunogenicity of a viral derived gene-product, that can lead to immune activation and removal of therapeutic T cells; the amount of time needed before the T cells are eliminated by HSV-tk; and the need for the first line therapeutic agent for cytomegalovirus (CMV) infections [105].